Insigneo Advisory Services LLC Purchases 2,243 Shares of Bruker Co. (NASDAQ:BRKR)

Insigneo Advisory Services LLC grew its holdings in shares of Bruker Co. (NASDAQ:BRKR) by 100.3% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,480 shares of the medical research company’s stock after purchasing an additional 2,243 shares during the quarter. Insigneo Advisory Services LLC’s holdings in Bruker were worth $285,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in BRKR. Lifestyle Asset Management Inc. boosted its stake in shares of Bruker by 1.3% during the 1st quarter. Lifestyle Asset Management Inc. now owns 12,534 shares of the medical research company’s stock worth $1,177,000 after acquiring an additional 158 shares during the last quarter. Nisa Investment Advisors LLC raised its holdings in Bruker by 20.0% in the 2nd quarter. Nisa Investment Advisors LLC now owns 991 shares of the medical research company’s stock worth $63,000 after purchasing an additional 165 shares during the period. Securian Asset Management Inc. raised its holdings in Bruker by 2.3% in the 2nd quarter. Securian Asset Management Inc. now owns 7,766 shares of the medical research company’s stock worth $496,000 after purchasing an additional 175 shares during the period. Park Place Capital Corp raised its holdings in Bruker by 19.4% in the 1st quarter. Park Place Capital Corp now owns 1,139 shares of the medical research company’s stock worth $107,000 after purchasing an additional 185 shares during the period. Finally, Assetmark Inc. raised its holdings in Bruker by 24.7% in the 4th quarter. Assetmark Inc. now owns 1,005 shares of the medical research company’s stock worth $74,000 after purchasing an additional 199 shares during the period. Institutional investors own 79.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on BRKR shares. The Goldman Sachs Group decreased their target price on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, July 9th. Jefferies Financial Group started coverage on Bruker in a report on Monday, June 3rd. They issued a “buy” rating and a $85.00 target price on the stock. Wells Fargo & Company began coverage on Bruker in a report on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 target price on the stock. Citigroup cut their price target on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. Finally, TD Cowen cut their price target on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research note on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $81.40.

Bruker Trading Up 0.3 %

Shares of Bruker stock opened at $70.67 on Friday. The firm has a market cap of $10.27 billion, a price-to-earnings ratio of 25.70, a PEG ratio of 2.43 and a beta of 1.18. The business has a 50-day moving average price of $65.08 and a 200-day moving average price of $72.11. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18. Bruker Co. has a twelve month low of $53.79 and a twelve month high of $94.86.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.52. The firm had revenue of $800.70 million during the quarter, compared to analyst estimates of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.50 earnings per share. Equities research analysts anticipate that Bruker Co. will post 2.61 EPS for the current fiscal year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Monday, September 2nd were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.28%. Bruker’s payout ratio is 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.